Actively Recruiting

Age: 18Years +
All Genders
NCT06528912

Standard Follow-up Program Neuro-oncology Patients (SFP Neuro-Oncology)

Led by University Medical Center Groningen · Updated on 2024-07-30

10000

Participants Needed

1

Research Sites

1152 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Standardised evaluation of baseline data regarding tumor-, patient- and treatment-characteristics as well as follow-up data regarding tumor- and clinical-outcome of neuro-oncology patients treated with radical/curative radiotherapy. Motive: Currently there is limited data on dose-effect relationships of tissues and structures in and around the brain. This lack of knowledge hampers patient selection for proton therapy, technique innovations, and accurate prediction of treatment outcome. Goal: To evaluate the selection for radiation treatment, obtain more knowledge on dose-effect relationships and enable insight in necessary treatment technique innovations that would improve treatment outcome.

CONDITIONS

Official Title

Standard Follow-up Program Neuro-oncology Patients (SFP Neuro-Oncology)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with neuro-oncological cancer
  • Patient receiving a radiotherapy dose XXX Gy
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Failure to comply with any of the inclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UMCG

Groningen, Netherlands, 9713GZ

Actively Recruiting

Loading map...

Research Team

H

Hiske vd Weide

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here